Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (31-40 of 278) with videos related to

Pageof 28
Sort By:
JAMA|March 9, 2016
Radiation With or Without Androgen Deprivation Therapy for Localized Prostate CancerJustin C Voog, Matthew R Smith, Jason A Efstathiou
Urologic Oncology|July 11, 2016
What is the best way to radiate the prostate in 2016?Dominic H Moon, Jason A Efstathiou, Ronald C Chen
Oncology (Williston Park, N.Y.)|November 29, 2013
T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. ConPhillip J Gray, William U Shipley, Jason A Efstathiou
Cancers|January 23, 2024
The Role of Proton Therapy for Prostate Cancer in the Setting of Hip ProsthesisMaryam Moteabbed, Mislav Bobić, Harald Paganetti, et al.
Hematology/Oncology Clinics of North America|May 7, 2021
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder CancerDavid J Konieczkowski, Jason A Efstathiou, Kent W Mouw
Cancer Journal (Sudbury, Mass.)|August 13, 2009
Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancerJason A Efstathiou, Alexei V Trofimov, Anthony L Zietman
Seminars in Radiation Oncology|June 15, 2013
Multidisciplinary care and management selection in prostate cancerAyal A Aizer, Jonathan J Paly, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics|June 25, 2021
Protons Versus Photons for Prostate Cancer: An Answer That Is Long Overdue and ComingJason A Efstathiou, Sophia C Kamran, Daniel E Spratt
European Urology|March 27, 2019
Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder CancerKent W Mouw, David T Miyamoto, Jason A Efstathiou
European Urology|March 15, 2016
Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control StudyPhillip J Gray, Jason A Efstathiou, William U Shipley
Pageof 28

Showing results (31-40 of 278) with videos related to

Sort By:
Pageof 28
JAMA|March 9, 2016
Radiation With or Without Androgen Deprivation Therapy for Localized Prostate CancerJustin C Voog, Matthew R Smith, Jason A Efstathiou
Urologic Oncology|July 11, 2016
What is the best way to radiate the prostate in 2016?Dominic H Moon, Jason A Efstathiou, Ronald C Chen
Oncology (Williston Park, N.Y.)|November 29, 2013
T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. ConPhillip J Gray, William U Shipley, Jason A Efstathiou
Cancers|January 23, 2024
The Role of Proton Therapy for Prostate Cancer in the Setting of Hip ProsthesisMaryam Moteabbed, Mislav Bobić, Harald Paganetti, et al.
Hematology/Oncology Clinics of North America|May 7, 2021
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder CancerDavid J Konieczkowski, Jason A Efstathiou, Kent W Mouw
Cancer Journal (Sudbury, Mass.)|August 13, 2009
Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancerJason A Efstathiou, Alexei V Trofimov, Anthony L Zietman
Seminars in Radiation Oncology|June 15, 2013
Multidisciplinary care and management selection in prostate cancerAyal A Aizer, Jonathan J Paly, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics|June 25, 2021
Protons Versus Photons for Prostate Cancer: An Answer That Is Long Overdue and ComingJason A Efstathiou, Sophia C Kamran, Daniel E Spratt
European Urology|March 27, 2019
Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder CancerKent W Mouw, David T Miyamoto, Jason A Efstathiou
European Urology|March 15, 2016
Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control StudyPhillip J Gray, Jason A Efstathiou, William U Shipley
Pageof 28